$RGEN
REPLIGEN CORP

2012 Q3 Form 10-Q Financial Statement

#000119312512459650 Filed on November 08, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2011 Q3
Revenue $15.10M $8.631M
YoY Change 75.0% 18.23%
Cost Of Revenue $6.419M $2.093M
YoY Change 206.69% 42.23%
Gross Profit $8.685M $6.538M
YoY Change 32.84% 18.87%
Gross Profit Margin 57.5% 75.75%
Selling, General & Admin $3.126M $2.493M
YoY Change 25.39% 37.54%
% of Gross Profit 35.99% 38.13%
Research & Development $2.433M $3.075M
YoY Change -20.88% -1.42%
% of Gross Profit 28.01% 47.03%
Depreciation & Amortization $890.0K $400.0K
YoY Change 122.5% -2.44%
% of Gross Profit 10.25% 6.12%
Operating Expenses $5.559M $5.568M
YoY Change -0.16% 12.9%
Operating Profit $2.188M $552.0K
YoY Change 296.38% -2.83%
Interest Expense -$7.000K $100.0K
YoY Change -107.0% 0.0%
% of Operating Profit -0.32% 18.12%
Other Income/Expense, Net -$500.0K $0.00
YoY Change
Pretax Income $1.790M $605.0K
YoY Change 195.87% 0.83%
Income Tax -$16.00K $0.00
% Of Pretax Income -0.89% 0.0%
Net Earnings $1.806M $605.0K
YoY Change 198.51% 0.83%
Net Earnings / Revenue 11.96% 7.01%
Basic Earnings Per Share $0.06 $0.02
Diluted Earnings Per Share $0.06 $0.02
COMMON SHARES
Basic Shares Outstanding 30.95M shares 30.80M shares
Diluted Shares Outstanding 31.26M shares 30.93M shares

Balance Sheet

Concept 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.30M $49.80M
YoY Change -39.16% -11.7%
Cash & Equivalents $18.39M $10.50M
Short-Term Investments $11.90M $39.30M
Other Short-Term Assets $1.100M $900.0K
YoY Change 22.22% -25.0%
Inventory $10.77M $2.500M
Prepaid Expenses
Receivables $7.636M $4.000M
Other Receivables $4.000M $2.800M
Total Short-Term Assets $53.79M $60.00M
YoY Change -10.35% -6.69%
LONG-TERM ASSETS
Property, Plant & Equipment $10.12M $1.800M
YoY Change 462.02% -30.77%
Goodwill $994.0K
YoY Change
Intangibles $7.377M
YoY Change
Long-Term Investments $12.40M $8.500M
YoY Change 45.88% 157.58%
Other Assets $200.0K $200.0K
YoY Change 0.0% 0.0%
Total Long-Term Assets $31.10M $12.60M
YoY Change 146.86% 51.81%
TOTAL ASSETS
Total Short-Term Assets $53.79M $60.00M
Total Long-Term Assets $31.10M $12.60M
Total Assets $84.90M $72.60M
YoY Change 16.94% 0.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.767M $600.0K
YoY Change 194.45% -33.33%
Accrued Expenses $7.269M $3.000M
YoY Change 142.3% 15.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.036M $4.200M
YoY Change 115.14% 13.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.900M $600.0K
YoY Change 216.68% 0.0%
Total Long-Term Liabilities $1.900M $600.0K
YoY Change 216.68% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.036M $4.200M
Total Long-Term Liabilities $1.900M $600.0K
Total Liabilities $10.94M $4.700M
YoY Change 132.68% 6.82%
SHAREHOLDERS EQUITY
Retained Earnings -$114.7M
YoY Change
Common Stock $310.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $73.70M $67.80M
YoY Change
Total Liabilities & Shareholders Equity $84.90M $72.60M
YoY Change 16.94% 0.0%

Cashflow Statement

Concept 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income $1.806M $605.0K
YoY Change 198.51% 0.83%
Depreciation, Depletion And Amortization $890.0K $400.0K
YoY Change 122.5% -2.44%
Cash From Operating Activities $2.470M $150.0K
YoY Change 1546.67% -86.73%
INVESTING ACTIVITIES
Capital Expenditures -$320.0K -$170.0K
YoY Change 88.24% 88.89%
Acquisitions
YoY Change
Other Investing Activities -$980.0K $3.390M
YoY Change -128.91% -41.25%
Cash From Investing Activities -$1.290M $3.220M
YoY Change -140.06% -43.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 760.0K -330.0K
YoY Change -330.3% -3400.0%
NET CHANGE
Cash From Operating Activities 2.470M 150.0K
Cash From Investing Activities -1.290M 3.220M
Cash From Financing Activities 760.0K -330.0K
Net Change In Cash 1.940M 3.040M
YoY Change -36.18% -55.49%
FREE CASH FLOW
Cash From Operating Activities $2.470M $150.0K
Capital Expenditures -$320.0K -$170.0K
Free Cash Flow $2.790M $320.0K
YoY Change 771.88% -73.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
65987000
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31111765 shares
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9794509
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.09
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10500112
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2719100 shares
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
910298
CY2011Q4 us-gaap Goodwill
Goodwill
994000
CY2011Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
499776
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18614715
CY2011Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5936578
CY2011Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
24850448
CY2011Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
9435350
CY2011Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
12011154
CY2011Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3563395
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
275258
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
715155
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2741738
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30714757 shares
CY2011Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
871086
CY2011Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15421436
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1422483
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
469046
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2469412
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2197226
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
566542
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119306614
CY2011Q4 us-gaap Assets
Assets
76056814
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.05
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
136881
CY2011Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
3206840
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2825414
CY2011Q4 us-gaap Inventory Net
InventoryNet
13363073
CY2011Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
11032
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76056814
CY2011Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5083852
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
200000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11167745
CY2011Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
4694
CY2011Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8161711
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30714757 shares
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7795239
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
113627
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6041038
CY2011Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1244451
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7463521
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000
CY2011Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3863100
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2823400 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
307148
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
366472
CY2011Q4 us-gaap Assets Current
AssetsCurrent
46894806
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7877296
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10737419
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
184872839
CY2011Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
24856786
CY2011Q4 rgen Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
142695
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1117341
CY2012Q3 us-gaap Goodwill
Goodwill
994000
CY2012Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1078661
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19886257
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
11918020
CY2012Q3 us-gaap Share Price
SharePrice
5.96
CY2012Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5968423
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
978000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1549700 shares
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
73703980
CY2012Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
24325021
CY2012Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
12417051
CY2012Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
12648183
CY2012Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3206689
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2070353
CY2012Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
294982
CY2012Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
631059
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2632460
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4678761
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18389977
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
978000
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3302618
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.32
CY2012Q3 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2
4000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4960713
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31054765 shares
CY2012Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
225351
CY2012Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
4676000
CY2012Q3 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions
8 Investment
CY2012Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11918020
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1766699
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
978000
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
476827
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1900102
CY2012Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2604990
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
11907564
CY2012Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
228353
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114686061
CY2012Q3 us-gaap Assets
Assets
84896632
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.11
CY2012Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
256765
CY2012Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
3962704
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7636346
CY2012Q3 us-gaap Inventory Net
InventoryNet
10768322
CY2012Q3 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
14241
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84896632
CY2012Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5179119
CY2012Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
200000
CY2012Q3 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
4191
CY2012Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8499866
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31054765 shares
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7376533
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2479847 shares
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1579403
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7269086
CY2012Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1763973
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
978000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
68100987
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
866000
us-gaap Share Based Compensation
ShareBasedCompensation
781645
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
187482
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
419267
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1212489
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
978000
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9035785
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000
CY2012Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1593210
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2625690 shares
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
310548
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1123333
CY2012Q3 us-gaap Assets Current
AssetsCurrent
53792710
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9769919
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10116338
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186500090
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.11
CY2012Q3 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
24335071
CY2012Q3 rgen Available For Sale Securities Debt Maturities One Through Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesOneThroughTwoYearsAmortizedCost
12417457
CY2012Q3 rgen Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
9000
CY2012Q3 rgen Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
12417051
CY2012Q3 rgen Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumber
930147 shares
CY2012Q3 rgen Marketable Securities Remaining Maturity
MarketableSecuritiesRemainingMaturity
P11M27D
us-gaap Costs And Expenses
CostsAndExpenses
23847097
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-36674
us-gaap Operating Income Loss
OperatingIncomeLoss
-1655609
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13250840
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-118734
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-5597
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1478924
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
69239
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1118425
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2174056
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
545318
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
705603
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
1211180
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1262077
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30800510 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2849296
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1481611
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1006654
us-gaap Operating Income Loss
OperatingIncomeLoss
4672522
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
32125076
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
309710
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M9D
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
67145
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6068700
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
36863333
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
704000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y1M2D
us-gaap Share Based Compensation
ShareBasedCompensation
743947
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10376357
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-350028
us-gaap Royalty Revenue
RoyaltyRevenue
8940648
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30800510 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
522515
us-gaap Cost Of Goods Sold
CostOfGoodsSold
5038713
us-gaap Revenues
Revenues
22191488
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
65381613
us-gaap Net Income Loss
NetIncomeLoss
-1481611
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7220847
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
42858
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue
953330
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
671455
us-gaap Interest Expense
InterestExpense
13484
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.21
dei Trading Symbol
TradingSymbol
RGEN
dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000730272
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Costs And Expenses
CostsAndExpenses
38780054
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.72
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
426100 shares
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>1.</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Basis of Presentation</b></font></td> </tr> </table> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">The consolidated financial statements included herein have been prepared by Repligen Corporation (the &#x201C;Company,&#x201D; &#x201C;Repligen&#x201D; or &#x201C;we&#x201D;) in accordance with generally accepted accounting principles in the United States (&#x201C;U.S. GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;), for quarterly reports on Form 10-Q and Article 10 of Regulation S-X and do not include all of the information and footnote disclosures required by U.S. GAAP. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company&#x2019;s Transition Report on Form 10-K for the nine months ended December&#xA0;31, 2011.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div>
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
156747
us-gaap Other Noncash Expense
OtherNoncashExpense
339433
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
290405 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2592824
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0517 pure
us-gaap Gain On Purchase Of Business
GainOnPurchaseOfBusiness
314244
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
886704
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6210164
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-299371
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.12
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
825061
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7222232
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
886704
us-gaap Royalty Revenue
RoyaltyRevenue
11327500
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
1593427
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-247093
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M13D
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31131749 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4672351
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4853878
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8147164
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30841344 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3036051
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
128800 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M16D
us-gaap Cost Of Goods Sold
CostOfGoodsSold
19036762
us-gaap Revenues
Revenues
43452576
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
339434
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
36337643
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
343932
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1602000 shares
us-gaap Net Income Loss
NetIncomeLoss
4602924
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9973013
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
755864
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
35000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
357190 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
250954
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
424735
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue
756444
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
757000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1087295
us-gaap Interest Expense
InterestExpense
42536
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.63
rgen Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liabilities Foreign Currency Translation
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitiesForeignCurrencyTranslation
103330
rgen Royalty Payment Rate
RoyaltyPaymentRate
0.15 pure
CY2011 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
CY2011Q3 us-gaap Costs And Expenses
CostsAndExpenses
8078952
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
552426
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5741920
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
607360
CY2011Q3 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
100000
CY2011Q3 us-gaap Share Based Compensation
ShareBasedCompensation
245000
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2011Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
52247
CY2011Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
137035 shares
CY2011Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00 pure
CY2011Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
418419
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30933832 shares
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
604673
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3074625
CY2011Q3 us-gaap Royalty Revenue
RoyaltyRevenue
2889458
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30796797 shares
CY2011Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
2092815
CY2011Q3 us-gaap Revenues
Revenues
8631378
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2046700 shares
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
604673
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2493093
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
12916587
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2187708
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
11123236
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-500414
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3913569
CY2012Q3 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
18000
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
288000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2012Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
95807
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
308211 shares
CY2012Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
594406
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31256273 shares
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1790306
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2433043
CY2012Q3 us-gaap Royalty Revenue
RoyaltyRevenue
3981059
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30948062 shares
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6418962
CY2012Q3 us-gaap Revenues
Revenues
15104295
CY2012Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
343932
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1431600 shares
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
1806489
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3126244
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16183
CY2012Q3 us-gaap Interest Expense
InterestExpense
-7205

Files In Submission

Name View Source Status
0001193125-12-459650-index-headers.html Edgar Link pending
0001193125-12-459650-index.html Edgar Link pending
0001193125-12-459650.txt Edgar Link pending
0001193125-12-459650-xbrl.zip Edgar Link pending
d404053d10q.htm Edgar Link pending
d404053dex311.htm Edgar Link pending
d404053dex312.htm Edgar Link pending
d404053dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20120930.xml Edgar Link completed
rgen-20120930.xsd Edgar Link pending
rgen-20120930_cal.xml Edgar Link unprocessable
rgen-20120930_def.xml Edgar Link unprocessable
rgen-20120930_lab.xml Edgar Link unprocessable
rgen-20120930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending